Methods and compositions related to glycoprotein-immunoglobulin fusions
US10080799B2 · kind B2 · utility
4Cited by
51References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2011 |
| Grant date | Sep 25, 2018 |
| Priority date | — |
| Expiry date | Aug 9, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for eliciting immune responses against HCV antigens. In particular embodiments, the compounds and methods elicit immune responses against all or a segment of HCV glycoprotein E1 and/or HCV glycoprotein E2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.